Production (Stage)
Kezar Life Sciences, Inc.
KZR
$4.40
$0.020.46%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 114.36M | 132.25M | 148.39M | 164.18M | 179.80M |
| Total Receivables | 2.20M | 424.00K | 1.09M | 1.69M | 3.06M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 798.00K | 1.09M | 1.44M | 766.00K | 1.03M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 2.96M | 3.73M | 5.46M | 983.00K | 1.74M |
| Total Current Assets | 120.32M | 137.49M | 156.38M | 167.62M | 185.61M |
|
|
|||||
| Total Current Assets | 120.32M | 137.49M | 156.38M | 167.62M | 185.61M |
| Net Property, Plant & Equipment | 4.27M | 4.78M | 5.29M | 5.78M | 8.02M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 674.00K | 2.42M | 2.42M | 6.52M | 5.50M |
| Total Assets | 125.26M | 144.68M | 164.09M | 179.92M | 199.13M |
|
|
|||||
| Total Accounts Payable | 1.97M | 3.65M | 3.46M | 2.26M | 5.06M |
| Total Accrued Expenses | 6.12M | 7.94M | 9.66M | 9.36M | 6.66M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 8.88M | 8.74M | 7.30M | 5.87M | 4.44M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 16.96M | 20.33M | 20.43M | 17.50M | 16.16M |
|
|
|||||
| Total Current Liabilities | 16.96M | 20.33M | 20.43M | 17.50M | 16.16M |
| Long-Term Debt | 3.87M | 5.11M | 6.35M | 7.59M | 8.83M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.35M | 2.33M | 3.26M | 4.15M | 5.02M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 22.19M | 27.77M | 30.04M | 29.24M | 30.01M |
|
|
|||||
| Common Stock & APIC | 554.36M | 551.58M | 548.22M | 545.04M | 541.90M |
| Retained Earnings | -451.06M | -434.50M | -414.28M | -393.97M | -372.42M |
| Treasury Stock & Other | -232.00K | -162.00K | 107.00K | -385.00K | -355.00K |
| Total Common Equity | 103.07M | 116.92M | 134.05M | 150.69M | 169.12M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 103.07M | 116.92M | 134.05M | 150.69M | 169.12M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 103.07M | 116.92M | 134.05M | 150.69M | 169.12M |
|
|
|||||